BSD Medical Corp (NASDAQ:BSDM)
The Company develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by medical therapies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Can a random number generator (www.random.org) produce the best 100 stock picks that will beat the market over the years? Let’s find out. :)
My process, for those interested:
I use www.random.org number generator to produce a number between 1 and 7,801. There are 7,801 stocks available to choose on the Motley Fool CAPS Game. Once I get a number, I go to the list, find that stock, and select that stock to outperform for the next five years.
Recs
Upcoming pump and dump.
Recs
The most advanced and sofisticated technology available. When the market will understand this breaktrought technique the stock will move in the 30s very quicly.
Recs
With the hiring of their sales team..BSD should have a very good 2011..
Recs
New technology is very promising.
Recs
As the population ages the need for cancer treatment will increase. From what I have researched ,this technology coupled with chemo, or radiation has a big impact on the destruction of cancer cells and increasing longivity of the patient.
Recs
Excellent potential----Great need for product--this one will move up to at least 10+
Recs
Small cap, cancer treatment that works, beginning to build up sales in US and China.
Recs
An Intuitive surgical style rocket shot or a fizzle on the launch pad? The recent approval of the MX180 and the patent on the applicators creates a near term blockbuster opportunity. Unlike thier million dollar machines the MX180 will sell for around 30 thousand. The high margin patented applicators for around 15 hundred each with up to 3 applicators used per treatment. The high margin revenue per device will likely average a million dollars per year times just 50 to 100 equipment placements and they have a an extremely profitable company with the enhanced opportunity for increased sales of their more costly hyperthermia medical devices. The big ticket devices already deliver the desired results and hold the future promise of helping to eradicate tumors while using smaller, safer doses of chemo. BSDM owns their certified production facility, have zero debt and ample cash. They are currently working on a major sales distribution agreement to accelerate the placements of their equipment. In a toxic world with an aging population I believe they are poised for enormous sales growth and profits.
Recs
It will expand business in China very quickly
Recs
This stock just recently received approval from FDA to market their product
Recs
Should have FDA approval on new unit within the next 30 days.
Recs
Good growth story for the long term. This stock can double in year or so.
Recs
FDA approval on BSD-2000 and sales ramping combine for some major upside potential.
Recs
This stock has great potential for growth but this is not a stock for the short term investor. Promising treatments could revolutionize medical treatments for many therapies but it is a waiting game with the FDA.
Recs
FDA approval anytime, M100 FDA submittal in March.
Recs
Promising technology STILL awaiting the same approval referenced on here in comment from April 07... BSD just received response from FDA specifying what needs to be done for application approval at this point... This is very promising, as the FDA offering its guidance suggests that only minor issues exist and further delays are hopefully insignificant.
The worst should be behind us here on this news, and price should settle and recover. Should prove to be an excellent entry point in the longterm, though it may take awhile to get back on track.
Recs
excellent cancer solution that betters the mortality rate when used in concert with radiation... cancer treatment center of america will increase market awareness
Recs
I checked, and I can't fault Fool Rich Duprey's April 25 article on BSM. No profits for 10 years, a cancer treatment of questionable value, the bulk of sales to a member of the board of directors. The SEC 10-Q is singularly uninformative. A lot of people seem to like BSM, but I can't see why.
Recs
Current return on assets is -13%... whether that is because of bad management or just that the products haven't hit the springboard yet is hard to tell. Also, their net income has consistently been under the water for the past three quarters.
It has its bright spots, but IMHO, its not a shining star.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 34 : 1 2 Next »